Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii

Clinical and Experimental Immunology

Volumn 119, Issue 2, 2000, Pages 293-298

  Sasaki, E ^a   Tashiro, T ^a   Kuroki, M ^a   Seki, M ^a   Miyazaki, Y ^a   Maesaki, S ^a   Tomono, K ^a   Kadota, J I ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colony stimulating factor; Fungicidal activity; Opportunistic infection; Trichosporonosis; Tumour necrosis factor alpha

Indexed keywords

RECOMBINANT COLONY STIMULATING FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FUNGICIDAL ACTIVITY; FUNGUS IMMUNITY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MALE; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; MYCOSIS; NEUTROPENIA; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; TRICHOSPORON; TRICHOSPORON ASAHII;

ANIMALS; ANTIBODIES; HUMANS; LUNG; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, PERITONEAL; MALE; MICE; MONOCYTES; MYCOSES; NEUTROPENIA; PHAGOCYTOSIS; TRICHOSPORON; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033984891     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01134.x     Document Type: Article

References (26)

1. Walsh TJ, Melcher GP, Rinaldi MG et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990; 28:1616-22.
2. Tashiro T, Nagai H, Kamberi P et al. Disseminated Trichosporon beigelii infection in patients with malignant diseases: Immunohistochemical study and review. Eur J Microbiol Infect Dis 1994; 13:218-24.
3. Gueho E, Smith MT, De Hoog GS et al. Contributions to a Revision of the Genus Trichosporon. Antonie Van Leeuwenhoek 1992; 61:289-316.
4. Nishiura Y, Nakagawa-Yoshida K, Suga M et al. Assignment and serotyping of Trichosporon species: The causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol 1997; 35:45-52.
5. Anaissie EJ, Hachem R, Karyotakis NC et al. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 1994; 38:2541-4.
6. Tashiro T, Nagai H, Nagaoka H et al. Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 1995; 108:190-5.
7. Kamberi P, Atsuro H, Takayoshi T et al. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice. Chemotherapy 1998; 44:55-62.
8. Richardson MD, Chung I. GM-CSF-modulated phagocytosis of Trichosporon beigelii by human neutrophils. J Med Microbiol 1997; 46:321-5.
9. Jensen J, Warner T, Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis 1994; 170:900-5.
10. Lyman CA, Garrett KF, Pizzo PA et al. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: Host defense against an emerging opportunistic pathogen. J Infect Dis 1994; 170:1557-65.
11. Vitt CR, Fidler JM, Ando D et al. Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J Infect Dis 1994; 169:369-74.
12. Roilides E, Sein T, Holmes A et al. Effect of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995; 172: 1028-34.
13. Nassar F, Brummer E, Stevens DA. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob Agents Chemother 1994; 38:2162-4.
14. Desai G, Nassar F, Bgummer E et al. Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophage: Role for reactive oxygen intermediates. J Med Mycol 1995; 43:224-9.
15. Bober LA, Grace MJ, Pugliese-Sivo C et al. The effects of colony stimulating factors on human monocyte cell function. Int J ImmunoPharmacol 1995; 17:385-92.
16. Warren MK, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 1986; 137:2281-5.
17. Hashimoto S, Yoda M, Yamada M et al. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp Hematol 1996; 24:123-8.
18. Motoyoshi K. Biological activities and clinical application of M-CSF. Int J Hematol 1998; 67:109-22.
19. Ferrante A, Nandoskar M, Walz A et al. Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 1988; 86:82-91.
20. Nagai H, Guo J, Choi H et al. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 1995; 172:1554-60.
21. Sakurai T, Wakimoto N, Yamada M et al. Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo. Immunopharmacol Immunotoxicol 1998; 20:79-102.
22. Nemunaitis J, Meyers JD, Buckner CD et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 1991; 78:907-13.
23. Nemunaitis J, Shannon-Dorcy K, Appelbaum FR et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993; 82:1422-7.
24. Ohno R, Miyawaki S, Hatake K et al. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: A double-blind controlled study. J Clin Oncol 1997; 15:2954-65.
25. Louie A, Baltch AL, Smith RP et al. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun 1994; 62:2761-72.
26. Muranaka H, Suga M, Nakagawa K et al. Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Infect Immun 1997; 65:3422-9.